A detailed history of Tru North Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tru North Capital Management, LLC holds 335 shares of LLY stock, worth $264,043. This represents 0.09% of its overall portfolio holdings.

Number of Shares
335
Previous 324 3.4%
Holding current value
$264,043
Previous $293 Million 1.18%
% of portfolio
0.09%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $8,493 - $10,560
11 Added 3.4%
335 $297 Million
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $11,597 - $14,544
-16 Reduced 4.71%
324 $293 Million
Q1 2024

Jun 17, 2024

BUY
$592.2 - $792.28 $201,348 - $269,375
340 New
340 $265 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tru North Capital Management, LLC Portfolio

Follow Tru North Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru North Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru North Capital Management, LLC with notifications on news.